{"title":"慢性炎症性风湿病期间的癌症筛查","authors":"Joanna Kedra , Raphaèle Seror","doi":"10.1016/j.monrhu.2022.05.005","DOIUrl":null,"url":null,"abstract":"<div><p>Cancer is a major public health issue, and screening for cancer is a current situation in our routine practice. The risk of cancer in patients with rheumatic diseases varies according to their personal medical history, underlying rheumatic disease and treatment. However, to date, no rheumatological learnt society has established specific recommendations for cancer screening in our patients with rheumatic diseases. In this review, we provide an overview of the risk of cancer in rheumatic diseases (related to the disease itself or its treatment), cancer screening in the general population and in immunocompromised subjects, and cancer screening in rheumatic diseases.</p></div>","PeriodicalId":101125,"journal":{"name":"Revue du Rhumatisme Monographies","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Dépistage d’un cancer au cours d’un rhumatisme inflammatoire chronique\",\"authors\":\"Joanna Kedra , Raphaèle Seror\",\"doi\":\"10.1016/j.monrhu.2022.05.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Cancer is a major public health issue, and screening for cancer is a current situation in our routine practice. The risk of cancer in patients with rheumatic diseases varies according to their personal medical history, underlying rheumatic disease and treatment. However, to date, no rheumatological learnt society has established specific recommendations for cancer screening in our patients with rheumatic diseases. In this review, we provide an overview of the risk of cancer in rheumatic diseases (related to the disease itself or its treatment), cancer screening in the general population and in immunocompromised subjects, and cancer screening in rheumatic diseases.</p></div>\",\"PeriodicalId\":101125,\"journal\":{\"name\":\"Revue du Rhumatisme Monographies\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revue du Rhumatisme Monographies\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1878622722000650\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue du Rhumatisme Monographies","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1878622722000650","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Dépistage d’un cancer au cours d’un rhumatisme inflammatoire chronique
Cancer is a major public health issue, and screening for cancer is a current situation in our routine practice. The risk of cancer in patients with rheumatic diseases varies according to their personal medical history, underlying rheumatic disease and treatment. However, to date, no rheumatological learnt society has established specific recommendations for cancer screening in our patients with rheumatic diseases. In this review, we provide an overview of the risk of cancer in rheumatic diseases (related to the disease itself or its treatment), cancer screening in the general population and in immunocompromised subjects, and cancer screening in rheumatic diseases.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
